Association between Q192R PON1 genetic polymorphism and major adverse cardiovascular events in patients treated with clopidogrel: an updated meta-analysis.

Mohitosh Biswas,Sumaiya Khatun Kali,Ashish Sarker,Chonlaphat Sukasem

EXPERT OPINION ON DRUG SAFETY（2023）

引用 0|浏览1

暂无评分

摘要

The results suggest that the Q192R PON1 genetic polymorphism has no significant impact on the risk of MACEs or bleeding events in patients treated with clopidogrel.

查看译文

关键词

Acute coronary syndrome,clopidogrel,PON1 genetic polymorphism,major adverse cardiovascular events,safety,efficacy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要